Transcriptomics

Dataset Information

0

Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice


ABSTRACT: Lack of non-invasive diagnostic tools and effective therapies constitute two of the major hurdles for a bona fide treatment against non-alcoholic steatohepatitis (NASH) progression and/or regression of nonalcoholic fatty liver disease (NAFLD). Nitro-oleic acid (OA-NO2) has been proven effective in multiple experimental models of inflammation and fibrosis. Thus, the potential benefit of in vivo administration of OA-NO2 to treat advanced NAFLD was studied in a model of long-term NASH diet-induced liver damage. Non-invasive imaging (e.g. photoacustic-ultrasound (PA-US)) was pursued to establish advanced experimental NASH in mice in which both steatosis and fibrosis were diagnosed prior experimental OA-NO2 therapy. CLAMS and NMR-based analysis demonstrates that OA-NO2 improves body composition and energy metabolism and inhibits hepatic triglyceride accumulation. PA-US imaging revealed a robust inhibition of liver steatosis and fibrosis by OA-NO2. RNA-sequencing analysis uncovered inflammation and fibrosis as major pathways suppressed by OA-NO2 administration, as well as regulation of lipogenesis and lipolysis pathways, with a robust inhibition of SREBP1-dependent lipogenic gene expression by OA-NO2. Global liver transcriptome in response to OA-NO2 was confirmed in vivo and in isolated hepatocytes. These results were further supported by histological analysis and quantification of lipid accumulation, lobular inflammation (F4/80 staining) and fibrosis (collagen deposition, αSMA staining) as well as established parameters of liver damage (ALT). In vitro studies indicate that OA-NO2 inhibits TG biosynthesis and accumulation in hepatocytes and inhibits fibrogenesis in human stellate cells. Taken together, OA-NO2 improve steatohepatitis and fibrosis and may constitute an effective therapeutic approach against advanced NAFLD that warrants further clinical evaluation.

ORGANISM(S): Mus musculus

PROVIDER: GSE126204 | GEO | 2019/02/08

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-05-31 | GSE167523 | GEO
2013-08-30 | E-GEOD-49541 | biostudies-arrayexpress
2022-05-09 | E-MTAB-11688 | biostudies-arrayexpress
2021-04-14 | E-MTAB-9815 | biostudies-arrayexpress
2024-06-04 | GSE254698 | GEO
2014-11-07 | E-GEOD-63067 | biostudies-arrayexpress
2011-07-12 | E-MEXP-3291 | biostudies-arrayexpress
2015-01-23 | E-GEOD-65220 | biostudies-arrayexpress
2022-04-05 | GSE174478 | GEO
2013-08-30 | E-GEOD-49542 | biostudies-arrayexpress